Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marey Messingschlager"'
Autor:
Loreen Thürmann, Matthias Klös, Sebastian D. Mackowiak, Matthias Bieg, Tobias Bauer, Naveed Ishaque, Marey Messingschlager, Carl Herrmann, Stefan Röder, Mario Bauer, Sascha Schäuble, Erik Faessler, Udo Hahn, Dieter Weichenhan, Oliver Mücke, Christoph Plass, Michael Borte, Erika von Mutius, Gabriele I. Stangl, Roger Lauener, Anne M. Karvonen, Amandine Divaret‐Chauveau, Josef Riedler, Joachim Heinrich, Marie Standl, Andrea von Berg, Beate Schaaf, Gunda Herberth, Michael Kabesch, Roland Eils, Saskia Trump, Irina Lehmann
Publikováno v:
Allergy.
Autor:
Leif E. Sander, Vladimir Gonçalves Magalhães, Sebastian Stricker, Saskia Trump, Irina Lehmann, Sven Laudi, Sven Klages, Johannes Liebig, Victor M. Corman, Jennifer Loske, Roland Eils, Soeren Lukassen, Bernd Timmermann, Marcus A. Mall, Christian Conrad, Markus Ralser, Anke Seegebarth, Marey Messingschlager, Birgit Sawitzki, Marco Binder, Jobst Röhmel, Loreen Thürmann, Robert Lorenz Chua
Publikováno v:
Nature Biotechnology
Children have reduced severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection rates and a substantially lower risk for developing severe coronavirus disease 2019 compared with adults. However, the molecular mechanisms underlying protec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecfb2677a3de000e1b18b5a18645c153
https://doi.org/10.1101/2021.06.24.21259087
https://doi.org/10.1101/2021.06.24.21259087
Autor:
Fabian Pott, Marco Binder, Martin Witzenrath, Christine Goffinet, Sven Laudi, Leif E. Sander, Irina Lehmann, Teresa G Krieger, Saskia Trump, Loreen Thürmann, Johannes Liebig, Sara Hadzibegovic, Robert Lorenz Chua, Uwe G. Liebert, Jan Philipp Albrecht, Lars Kaderali, Sven Twardziok, Christian Conrad, Bianca P Hennig, Bettina Heidecker, Jennifer Loske, Alessia Lena, Markus S. Anker, Naveed Ishaque, Soeren Lukassen, Christian Drosten, Maria Theresa Völker, Christina Klasa, Sarah Dorothea Müller, Marey Messingschlager, Roland Eils, Florian Kurth, Ulf Landmesser, Victor M. Corman, Julia Kazmierski, Jürgen Eils
In COVID-19, hypertension and cardiovascular diseases have emerged as major risk factors for critical disease progression. Concurrently, the impact of the main anti-hypertensive therapies, angiotensin-converting enzyme inhibitors (ACEi) and angiotens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f9c069c41af30f3665a116e93ee3444
https://doi.org/10.1101/2020.09.22.20199471
https://doi.org/10.1101/2020.09.22.20199471
Autor:
Sven Twardziok, Irina Lehmann, Sven Laudi, Johannes Liebig, Robert Lorenz Chua, Soeren Lukassen, Sarah Dorothea Müller, Bettina Heidecker, Marco Binder, Jennifer Loske, Martin Witzenrath, Florian Kurth, Christine Goffinet, Christina Klasa, Jan Philipp Albrecht, Teresa G Krieger, Uwe G. Liebert, Saskia Trump, Leif E. Sander, Loreen Thürmann, Julia Kazmierski, Sara Hadzibegovic, Thore Bürgel, Marey Messingschlager, Alessia Lena, Christian Drosten, Maria Theresa Völker, Victor M. Corman, Ulf Landmesser, Jürgen Eils, Markus S. Anker, Naveed Ishaque, Lars Kaderali, Roland Eils, Fabian Pott, Jakob Steinfeldt, Christian Conrad, Bianca P Hennig
Publikováno v:
Nature Biotechnology
In coronavirus disease 2019 (COVID-19), hypertension and cardiovascular diseases are major risk factors for critical disease progression. However, the underlying causes and the effects of the main anti-hypertensive therapies-angiotensin-converting en